MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis

ConclusionOur study suggests that MCP-1 mediated pathways could be potential therapeutic targets for the treatment of TNBC, and could reduce cancer health disparities.

http://link.springer.com/10.1007/s10549-018-4760-8

Source: Breast Cancer Research and Treatment - June 28, 2018 Category: Cancer & Oncology Source Type: research